Gene: RPL22
Official Full Name: ribosomal protein L22provided by HGNC
Gene Summary: Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a cytoplasmic ribosomal protein that is a component of the 60S subunit. The protein belongs to the L22E family of ribosomal proteins. Its initiating methionine residue is post-translationally removed. The protein can bind specifically to Epstein-Barr virus-encoded RNAs (EBERs) 1 and 2. The mouse protein has been shown to be capable of binding to heparin. Transcript variants utilizing alternative polyA signals exist. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. It was previously thought that this gene mapped to 3q26 and that it was fused to the acute myeloid leukemia 1 (AML1) gene located at 21q22 in some therapy-related myelodysplastic syndrome patients with 3;21 translocations; however, these fusions actually involve a ribosomal protein L22 pseudogene located at 3q26, and this gene actually maps to 1p36.3-p36.2. [provided by RefSeq, Jul 2008]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA13860 | RPL22 Knockout cell line (AC16) | Human | RPL22 | 1:3-1:4 | negative | Online Inquiry |
| KOA29303 | RPL22 Knockout cell line (BEAS-2B) | Human | RPL22 | 1:3~1:4 | negative | Online Inquiry |
| KOA44736 | RPL22 Knockout cell line (U-2932) | Human | RPL22 | 1:2-1:4 | negative | Online Inquiry |
| KOA60117 | RPL22 Knockout cell line (TPC-1) | Human | RPL22 | 1:5-1:8 | negative | Online Inquiry |
| KOA75542 | RPL22 Knockout cell line (NCM460) | Human | RPL22 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.